Inventia Healthcare Limited Domperidone Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Domperidone Export Records India — #11 Exporter, 36 Shipments, $419.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Domperidone

India Pharmaceutical Trade Intelligence

$29.6M493 Suppliers115 CountriesHS 30049039

ExportsIndia → AFGHANISTAN19.4%India → FRANCE12.2%

ImportsGERMANY → India$2.7K BELGIUM → India$1.0K

#1 Supplier: COMBITIC GLOBAL #1 Buyer: SHAMS NOORI

Inventia Healthcare Limited — Domperidone Exporter #11 | $419.2K Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Domperidone Exporter Profile

Indian Pharmaceutical Exporter · #11 for Domperidone · $419.2K export value · DGFT Verified

Inventia Healthcare Limited is the #11 Indian exporter of Domperidone with $419.2K in export value and 36 verified shipments. Inventia Healthcare Limited holds a 1.4% market share in Domperidone exports across 8 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Domperidone Export Profile: Buyers & Destinations

Inventia Healthcare Limited Domperidone export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Domperidone?

Country	Value	Shipments	Share
PHILIPPINES	$150.0K	3	39.7%
MYANMAR	$78.6K	12	20.8%
POLAND	$61.5K	6	16.3%
UGANDA	$47.0K	5	12.4%

Who Are the Top Buyers of Domperidone from Inventia Healthcare Limited?

Buyer	Country	Value	Orders
I.E. MEDICA INC.	PHILIPPINES	$150.0K	3
MEGA LIFESCIENCES LLC	POLAND	$61.5K	6
MYIT MAHAR TRADING CO LIMITED	MYANMAR	$36.5K	6
ROYAL PHARMA 2011 LTD	UGANDA	$31.0K	3
MYIT MAHAR TRADING CO LTD	MYANMAR	$29.6K	4
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$12.5K	2
FC MEGA WE CARE LLC	UZBEKISTAN	$10.3K	3
MEGA LIFESCIENCES GHANA LIMITED	GHANA	$10.1K	1
MEGA LIFESCIENCES GHANA LTD	GHANA	$10.0K	1
ABACUS PHARMA(A) LIMITED	UGANDA	$8.2K	1

Inventia Healthcare Limited supplies Domperidone to 15 buyers globally. The largest buyer is I.E. MEDICA INC. (PHILIPPINES), followed by MEGA LIFESCIENCES LLC (POLAND) and MYIT MAHAR TRADING CO LIMITED (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Domperidone Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
PRAZOLE PLUS (ENTERIC COATED PANTOPRAZOLE SODIUM 40MG AND DOMPERIDONE SR 30MG CAPSULES) (ACT.QTY:33948X3X10)	$50.0K	1
PRAZOLE PLUS ( ENTERIC COATED PANTOPRAZOLE SODIUM 40MG AND DOMPERIDONE SR 30MG CAPSULES ) (QTY. 33990 CRTNS X 3X10)	$50.0K	1
PRAZOLE PLUS ( ENTERIC COATED PANTOPRAZOLE SODIUM 40MG AND DOMPERIDONE SR 30MG CAPSULES ) (QTY. 33689 CRTNS X 3X10)	$50.0K	1
BRAND RABLET-D(ENTERIC COATED RABEPRAZOLE SODIUM 20MG AND DOMPERIDONE SR 30 MGCAPSULES)(PACK SIZE3X10)(NOS=CARTONS)NOS	$22.1K	2
LIMZER -(EACH ENTERIC COATED CAPSULE: OMEPRAZOLE 20 MG & DOMPERIDONESR 30 MG)	$20.7K	1
LIMZER -(EACH ENTERIC COATED CAPSULE OMEPRAZOLE 20 MG & DOMPERIDONE SR 30 MG)NOS	$20.1K	3
LIMZER (ENTERIC COATED OMEPRAZOLE AND DOMPERIDONE SR CAPSULES)	$18.7K	2
BRAND: RABLET-D (ENTERIC COATED RABEPRAZOLE SODIUM 20MG AND DOMPERIDONE SR 30 MGCAPSULES) (QTY: 10920 CARTONS X3X10)	$15.3K	1
Brand Rablet-D Enteric coated Rabeprazole Sodium 20mg and Domperidone SR 30 mgcapsules PACK SIZE3x10NOS=CARTONS	$14.4K	2
BRAND:RABLET-D (ENTERIC COATED RABEPRAZOLE SODIUM 20MG AND DOMPERIDONE SR 30 MG CAPSULES) (PACK SIZE:3X10)(NO	$14.3K	1

Inventia Healthcare Limited exports 31 distinct Domperidone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PRAZOLE PLUS (ENTERIC COATED PANTOPRAZOLE SODIUM 40MG AND DO with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Inventia Healthcare Limited Compare to Nearest Domperidone Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	ARISTO PHARMACEUTICALS PRIVATE LIMITED	$772.7K	33	4	$23.4K
10	THE MADRAS PHARMACEUTICALS	$614.6K	25	1	$24.6K
11	INVENTIA HEALTHCARE LIMITED ★	$419.2K	36	8	$11.6K
12	MEDLEY PHARMACEUTICALS LIMITED	$372.3K	50	4	$7.4K
13	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$365.6K	29	2	$12.6K

Inventia Healthcare Limited ranks #11 among 493 Indian Domperidone exporters. Average shipment value of $11.6K compared to the market average of $31.0K. The closest competitors by value are ARISTO PHARMACEUTICALS PRIVATE LIMITED and THE MADRAS PHARMACEUTICALS.

Which Indian Ports Ship Domperidone Exports?

Port	Shipments	% Share
SAHAR AIR	503	12.0%
SAHAR AIR CARGO ACC (INBOM4)	487	11.6%
DELHI AIR CARGO ACC (INDEL4)	332	7.9%
DELHI AIR	251	6.0%
NHAVA SHEVA SEA (INNSA1)	224	5.3%
Bombay Air	140	3.3%
JNPT/ NHAVA SHEVA SEA	131	3.1%
JNPT	124	3.0%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Domperidone Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Domperidone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 36 individual customs records matching Inventia Healthcare Limited exporting Domperidone, covering 31 formulations to 8 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 989+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Domperidone

Domperidone

Inventia Healthcare Limited — Domperidone Exporter Profile

Inventia Healthcare Limited — Domperidone Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Domperidone?

Who Are the Top Buyers of Domperidone from Inventia Healthcare Limited?

What Is India's Total Domperidone Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Domperidone Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Domperidone Exporters?

What Domperidone Formulations Does Inventia Healthcare Limited Export?

How Does Inventia Healthcare Limited Compare to Nearest Domperidone Exporters?

Which Indian Ports Ship Domperidone Exports?

What Other Gastrointestinal Products Does Inventia Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Domperidone Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Domperidone Export Data from Inventia Healthcare Limited

Domperidone Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source